RxDoctor Payments Data

Cathy Bryson

Family · Bluefield, VANPI 1215247325

Payments from drug & device makers

$2,540in general payments, 2019–2025

Across 143 payments — averaging $17.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$732
  • Bayer$302
  • AstraZeneca$228
  • AbbVie$194
  • Lilly USA, LLC$138
  • Abbott$113
  • plus $832 from 18 others

What the payments were for

  • Food & beverage$2,540100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,540 in reported general payments places this provider in the 85th percentile of 4,332 family providers in Virginia.

See all family providers in Virginia

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide89$134,358
EliquisApixaban82$85,983
Trelegy ElliptaFluticasone/Umeclidin/Vilanter25$30,089
JardianceEmpagliflozin39$27,781
JanuviaSitagliptin Phosphate23$23,931
Breztri AerosphereBudesonide/Glycopyr/Formoterol15$14,409
XareltoRivaroxaban18$11,161
TrulicityDulaglutide12$10,913
SymbicortBudesonide/Formoterol Fumarate22$6,980
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog14$5,548
Fluticasone-SalmeterolFluticasone Propion/Salmeterol26$4,059
SynthroidLevothyroxine Sodium35$3,153
Albuterol Sulfate HfaAlbuterol Sulfate94$2,746
Levothyroxine Sodium190$2,596
PremarinEstrogens, Conjugated13$2,537

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$732$134,35889 claims
PfizerEliquis, Premarin$58$88,52095 claims
GSKTrelegy Ellipta$54$30,08925 claims
Boehringer IngelheimJardiance$37$27,78139 claims
AstraZenecaBreztri Aerosphere, Symbicort$228$21,39037 claims
Lilly USA, LLCTrulicity$138$10,91312 claims
AbbVieSynthroid$194$3,15335 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,332 family providers in Virginia.

Other family in Bluefield

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →